Human medicinehttps://www.ema.europa.eu/en/homepageHuman medicineen-gbCopyright: (C) European Medicines AgencyWed, 17 Jul 2024 11:35:17 +0200Wed, 05 Jun 2024 16:15:00 +0200Human medicines European public assessment report (EPAR): Erbitux, cetuximab, Date of authorisation: 29/06/2004, Revision: 30, Status: Authorisedhttps://www.ema.europa.eu/en/medicines/human/EPAR/erbituxHuman medicines European public assessment report (EPAR): Erbitux, cetuximab, Date of authorisation: 29/06/2004, Revision: 30, Status: Authorisedhttps://www.ema.europa.eu/en/medicines/human/EPAR/erbituxWed, 05 Jun 2024 16:15:00 +0200Human medicineErbitux-H-C-558-II-0026 : EPAR - Assessment report - Variationhttps://www.ema.europa.eu/system/files/documents/variation-report/wc500029118_en.pdfErbitux-H-C-558-II-0026 : EPAR - Assessment report - Variationhttps://www.ema.europa.eu/system/files/documents/variation-report/wc500029118_en.pdfThu, 18 Dec 2008 01:00:00 +0100Human medicine